Brief: Syndax Announces Pricing Of $200 Million Public Offering Of Common Stock
Dec 14 (Reuters) - Syndax Pharmaceuticals Inc SNDX.O :
* SYNDAX ANNOUNCES PRICING OF $200 MILLION PUBLIC OFFERING
OF
COMMON STOCK
* SYNDAX PHARMACEUTICALS INC SAYS PRICING OF AN UNDERWRITTEN
PUBLIC OFFERING OF 10.8 MILLION SHARES AT $18.50 PER SHARE
Source text for Eikon: ID:nPn2KwCHKa
Further company coverage: SNDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syndax Pharmaceuticals
See all newsBrief: Syndax Announces Topline Results From Maxpire Phase 2 Trial Of Axatilimab In Idiopathic Pulmonary Fibrosis
Syndax says mid-stage trial of lung disease treatment fails main goal, ends development
Syndax Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Syndax Q2 revenue jumps 92% on Revuforj, Niktimvo demand
Brief: Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million